Related Experiment Video
Updated: May 5, 2026
08:01
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
31.0K
Detection of Hematological Malignancies Using N-NOSE (Nematode-NOSE)
Shingen Nakamura1, Hideyuki Hatakeyama2, Sumiko Yoshida3,4
1Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Hematological Oncology
|March 29, 2025
Summary
A new urine test, N-NOSE, shows promise for detecting hematological cancers like leukemia and multiple myeloma. This non-invasive screening tool accurately identifies cancer markers and can monitor treatment response.
Area of Science:
- Hematology
- Oncology
- Biotechnology
Background:
- Hematological malignancies often present with vague symptoms, necessitating improved early detection methods.
- Current diagnostic approaches can be invasive or lack sensitivity for certain blood cancers.
- There is a critical need for simple, reliable, and non-invasive screening tools for hematological malignancies.
Purpose of the Study:
- To evaluate the diagnostic performance of the N-NOSE test in patients with various hematological malignancies.
- To assess the utility of N-NOSE for monitoring treatment response in these patients.
- To determine the potential of N-NOSE as a non-invasive screening tool for hematological cancers.
Main Methods:
- The study involved collecting urine samples from 30 healthy controls and 89 patients diagnosed with hematological malignancies.
- The N-NOSE test, utilizing the chemotaxis response of Caenorhabditis elegans to urine odors, was employed.
- Performance was assessed at diagnosis and during treatment, with analysis of N-NOSE index values against clinical data.
Main Results:
- N-NOSE demonstrated high positivity rates in treatment-naïve patients with leukemia and multiple myeloma (over 90%).
- Malignant lymphoma showed a slightly lower positivity rate (under 80%), with some false negatives potentially linked to steroid use or hemodialysis.
- N-NOSE index values correlated with cancer presence and decreased significantly in patients achieving clinical response to chemotherapy.
Conclusions:
- The N-NOSE test shows significant potential as a sensitive, non-invasive screening tool for hematological malignancies.
- The test is particularly promising for the early detection of multiple myeloma.
- N-NOSE may also serve as a valuable tool for monitoring therapeutic response in patients with hematological cancers.
